Clonidine
- Product NDC
- 68134-603
- 11-digit product format
- 681340603
- Labeler code
- 68134
- Product ID
- 68134-603_0eb6eb87-c779-3b79-e063-6294a90a5944
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clonidine
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- PALMETTO PHARMACEUTICALS INC.
- Application
- NDA022500
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2022-03-01
- Substance
- CLONIDINE
- Active strength
- .17 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Clonidine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CLONIDINE | .17 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | MN3L5RMN02 |
| Rxcui | 885880 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68134-603-30 | Clonidine | 30 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 30 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68134-603 | CLONIDINE TABLET, EXTENDED RELEASE [PALMETTO PHARMACEUTICALS INC.] | 2 | Current NDC, Legacy NDC, 1 package rows | 20240113_e93324f1-ad83-7bbe-e053-2995a90a8c9e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68134-603-30 | 68134060330 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68134-603-30) | 2022-03-01 | 0000-00-00 | No | No | Current |